Novavax, Inc. (NVAX)
8.19
-0.48
(-5.54%)
USD |
NASDAQ |
Jan 14, 16:00
8.01
-0.18
(-2.20%)
After-Hours: 20:00
Novavax Market Cap: 1.331B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 145.44B |
| Moderna, Inc. | 15.86B |
| Merck & Co., Inc. | 275.53B |
| Arcturus Therapeutics Holdings, Inc. | 219.63M |
| Denali Therapeutics, Inc. | 2.853B |
Market Cap Related Metrics
| PE Ratio | 4.630 |
| PS Ratio | 1.303 |
| Price | 8.19 |
| Earnings Yield | 21.60% |
| Operating PE Ratio | 3.328 |
| Normalized PE Ratio | 3.467 |